Canonical Smad3 signaling and ERK/Sp1 signaling pathways were also crucial for the TGF‐β‐induced upregulation of EGFR expression and the enhancement of migration and invasion abilities of breast cancer cells. The gene discussed is SMAD3; the disease is breast carcinoma.